SBIR TOPIC 091 PHASE II: DEVELOPMENT OF A NEW TLR4 AGONIST FOR THE TREATMENT OF ALLERGIC RHINITIS
$1,836,453
| Recipient | INIMMUNE CORP UEI EF8AMXMGG8W5 |
|---|---|
| Award ID | 75N93021C00044 |
| Award amount | $1,836,453 |
| Award type | DEFINITIVE CONTRACT |
| Awarding agency | Department of Health and Human Services — National Institutes of Health |
| NAICS | 541715 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) |
| PSC | AN12 |
| Set-aside | Small business |
| Start date | Sep 1, 2021 |
| End date | Aug 31, 2023 |
| Place of performance | MISSOULA, MT |
| Record updated | Nov 10, 2022 |
View the official award record
More awards won by INIMMUNE CORP
DEVELOPMENT OF SAS A SYNTHETIC AS01-LIKE ADJUVANT SYSTEM FOR INFLUENZA VACCINES
Department of Health and Human Services · $7,776,786 · Sep 30, 2023
PRODUCTION OF SYNTHETIC ADJUVANT SYSTEM (SAS): A SYNERGISTIC COMBINATION OF SYNTHETIC ADJUVANT COMPONENTS
Department of Health and Human Services · $1,992,471 · Jun 1, 2020
ADJUVANT DISCOVERY FOR VACCINES AND FOR AUTOIMMUNE AND ALLERGIC DISEASES
Department of Health and Human Services · $598,808 · Sep 1, 2021
Our catalog shows awards with a value or ceiling of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.
Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. $0 today for 14 days (card required), then $49.99/month.
Search open bids